Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HALO
TEM
Add up to 3 more stocks
HALO
Halozyme Therapeutics, Inc.
+2.60%
$111.13+2.82Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$13.18B
52W Range
$61.23 - $116.85
TEM
Tempus AI, Inc.
-11.88%
$73.63-9.92Delayed quote: Oct 6, 2026, 2:30 PM EDT
Market Cap
$12.90B
52W Range
$40.77 - $104.32
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 33.17 | N/A |
| Forward P/E | 13.21 | N/A |
| PEG Ratio | 1.44 | N/A |
| P/B Ratio | 91.83 | 28.99 |
| P/S Ratio | 7.92 | 9.01 |
| P/FCF Ratio | 16.35 | N/A |
| EV/EBITDA | 14.38 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 78.2% | 64.0% |
| Operating Margin | 56.8% | -19.8% |
| Net Margin | 24.9% | -17.8% |
| ROE | 288.1% | -57.2% |
| ROA | 16.1% | -10.8% |
| ROIC | 27.4% | -14.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.71 | 3.30 |
| Quick Ratio | 2.31 | 3.16 |
| Debt/Equity | 14.95 | 3.25 |
| Interest Coverage | 45.03 | -3.60 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.